Overview Fundamentals API Earnings EOD API Sample Code Pricing

PAVmed Inc (PAVM NASDAQ) stock market data APIs

$0.95 -0.09(-8.7%) as of July 16, 2024
Price chart is built with Anychart

PAVmed Inc. focuses on acquiring, developing, and commercializing novel products that target unmet needs in the United States. The company's lead products include CarpX, a patented, single-use, disposable, and minimally invasive surgical device for use in the treatment of carpal tunnel syndrome; EsoCheck Esophageal Cell Collection Device, which consists of diagnostic test that serves as a testing tool for preventing esophageal adenocarcinoma deaths, through early detection of esophageal precancer in at-risk gastroesophageal reflux disease, including chronic heartburn and acid reflux or simply reflux in patients; and EsoGuard, a bisulfite-converted next-generation sequencing DNA assay performed on surface esophageal cells collected with EsoCheck. Its product pipeline also comprises EsoCure EsoCure Esophageal Ablation Device for treating dysplastic BE; PortIO, an implantable intraosseous vascular access device; and Veris cancer care platform. The company was formerly known as PAXmed Inc. and changed its name to PAVmed Inc. in April 2015. PAVmed Inc. was incorporated in 2014 and is headquartered in New York, New York.

PAVmed Inc Financial Data Overview

11 177 K
9 432 K
3 016 K
Our easy-to-use no-coding solutions help you get the data effortlessly:

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'PAVM',
Type: 'Common Stock',
Name: 'PAVmed Inc',
Exchange: 'NASDAQ',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG00DGWP2L8',
CIK: '1624326',
EmployerIdNumber: '47-1214177',
FiscalYearEnd: 'December',
IPODate: '2016-04-28',
InternationalDomestic: 'Domestic',
Sector: 'Healthcare',
Industry: 'Medical Devices',
HomeCategory: 'Domestic Primary',
IsDelisted: false,

PAVmed Inc Fundamental Data is available in our Financial Data APIs

  • Net Revenue 3 016 K
  • EBITDA -59 639 000
  • Earnings Per Share -9
  • Income Statements
  • Balance Sheets
  • Cash flows
Get sample
of Fundamental API Data

Get PAVmed Inc Earnings via APIs

  • Latest Release 2024-05-13
  • EPS/Forecast -1.67

Get PAVmed Inc End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
Do you have any questions?